Hepatoprotectant is critical for the treatment of liver disease. This study first reported the application of a liver chip in the hepatoprotective effect assessment. We first established a biomimetic sinusoid-on-a-chip by laminating four types of hepatic cell lines (HepG2, HUVEC, LX-2, and U937 cells) in a single microchannel with the help of laminar flow in the microchannel and some micro-fences. This chip was straightforward to fabricate and operate and was able to be long-term cultured. It also demonstrated better hepatic activity (cell viability, albumin synthesis, urea secretion, and cytochrome P450 enzyme activities) over the traditional planar cell culture model. Then, we loaded three hepatoprotectants (tiopronin, bifendatatum, and glycyrrhizinate) into the chip followed by the addition of acetaminophen as a toxin. We successfully observed the hepatoprotective effect of these hepatoprotectants in the chip, and we also found that bifendatatum predominantly reduced alanine transaminase secretion, tiopronin predominantly reduced lactate dehydrogenase secretion, and glycyrrhizinate predominantly reduced aspartate transaminase secretion, which revealed the different mechanisms of these hepatoprotectants and provided a clue for following molecular biological study of the protecting mechanism.

1.
M.
Pinzani
and
K.
Rombouts
, “
Liver fibrosis: From the bench to clinical targets
,”
Dig. Liver Dis.
36
(
4
),
231
242
(
2004
).
2.
P.
Godoy
,
N. J.
Hewitt
,
U.
Albrecht
 et al., “
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
,”
Arch. Toxicol.
87
(
8
),
1315
1530
(
2013
).
3.
J. H.
Sung
,
Y. I.
Wang
,
N.
Narasimhan Sriram
 et al., “
Recent advances in body-on-a-chip systems
,”
Anal. Chem.
91
(
1
),
330
351
(
2018
).
4.
V. M.
Lauschke
,
D. F. G.
Hendriks
,
C. C.
Bell
 et al., “
Novel 3D culture systems for studies of human liver function and assessments of the hepatotoxicity of drugs and drug candidates
,”
Chem. Res. Toxicol.
29
(
12
),
1936
1955
(
2016
).
5.
B. R.
Ware
and
S. R.
Khetani
, “
Engineered liver platforms for different phases of drug development
,”
Trends Biotechnol.
35
(
2
),
172
183
(
2016
).
6.
J.
Deng
,
X.
Zhang
,
Z.
Chen
 et al., “
A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction
,”
Biomicrofluidics
13
(
2
),
24101
(
2019
).
7.
J.
Deng
,
W.
Wei
,
Z.
Chen
 et al., “
Engineered liver-on-a-chip platform to mimic liver functions and its biomedical applications: A review
,”
Micromachines
10
(
10
),
676
(
2019
).
8.
A.
Petrosyan
,
P.
Cravedi
,
V.
Villani
 et al., “
A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier
,”
Nat. Commun.
10
(
1
),
3656
(
2019
).
9.
S. G.
Rayner
,
K. T.
Phong
,
J.
Xue
 et al., “
Reconstructing the human renal vascular-tubular unit in vitro
,”
Adv. Healthcare Mater.
7
(
23
),
1801120
(
2018
).
10.
K. H.
Benam
,
R.
Villenave
,
C.
Lucchesi
, et al., “
Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro
,”
Nat. Methods
13
(
2
),
151
157
(
2016
).
11.
X.
Yang
,
K.
Li
,
X.
Zhang
 et al., “
Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing
,”
Lab Chip
10
,
1039
(
2018
).
12.
B. M.
Maoz
,
A.
Herland
,
E. A.
Fitzgerald
 et al., “
A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells
,”
Nat. Biotechnol.
36
(
9
),
865
874
(
2018
).
13.
E.
Karzbrun
,
A.
Kshirsagar
,
S. R.
Cohen
 et al., “
Human brain organoids on a chip reveal the physics of folding
,”
Nat. Phys.
14
(
5
),
515
522
(
2018
).
14.
Y. S.
Zhang
,
J.
Aleman
,
S. R.
Shin
 et al., “
Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors
,”
Proc. Natl. Acad. Sci. U.S.A.
114
(
12
),
E2293
E2302
(
2017
).
15.
A.
Guan
,
P.
Hamilton
,
Y.
Wang
 et al., “
Medical devices on chips
,”
Nat. Biomed. Eng.
1
(
3
),
45
(
2017
).
16.
K.
Rennert
,
S.
Steinborn
,
M.
Gröger
 et al., “
A microfluidically perfused three dimensional human liver model
,”
Biomaterials
71
,
119
131
(
2015
).
17.
L.-D.
Ma
,
Y.-T.
Wang
,
J.-R.
Wang
 et al., “
Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe in situ perfusion culture of 3D hepatic spheroids
,”
Lab Chip
17
(
18
),
2547
2562
(
2018
).
18.
Y.
Du
,
N.
Li
,
H.
Yang
 et al., “
Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip
,”
Lab Chip
17
(
5
),
782
794
(
2017
).
19.
Y.
Weng
,
S.
Chang
,
M.
Shih
 et al., “
Scaffold-free liver-on-a-chip with multiscale organotypic cultures
,”
Adv. Mater.
29
(
36
),
1701545
(
2017
).
20.
S.
Mi
,
X.
Yi
,
Z.
Du
 et al., “
Construction of a liver sinusoid based on the laminar flow on chip and self-assembly of endothelial cells
,”
Biofabrication
10
(
2
),
25010
(
2018
).
21.
Y.
Toh
,
T.
Lim
,
D.
Tai
 et al., “
A microfluidic 3D hepatocyte chip for drug toxicity testing
,”
Lab Chip
14
(
9
),
2026
(
2009
).
22.
L.
Prodanov
,
R.
Jindal
,
S. S.
Bale
 et al., “
Long-term maintenance of a microfluidic 3D human liver sinusoid
,”
Biotechnol. Bioeng.
113
(
1
),
241
246
(
2016
).
23.
A.
Rocco
, “
Alcoholic disease: Liver and beyond
,”
World J. Gastroenterol.
20
(
40
),
14652
(
2014
).
24.
C.
Li
,
Y.
Ming
,
Z.
Wang
 et al., “
GADD45α alleviates acetaminophen-induced hepatotoxicity by promoting AMPK activation
,”
Cell. Mol. Life Sci.
76
(
1
),
129
145
(
2019
).

Supplementary Material

You do not currently have access to this content.